Open-Label, Parallel Group, Multiple-dose Study of Ceftobiprole to Evaluate the Plasma Pharmacokinetics in Adults in Intensive Care Units.
Phase of Trial: Phase I
Latest Information Update: 28 Apr 2015
At a glance
- Drugs Ceftobiprole medocaril (Primary)
- Indications Community-acquired pneumonia; Nosocomial pneumonia; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors Basilea Pharmaceutica
- 28 Apr 2015 Results presented at the 25th European Congress of Clinical Microbiology and Infectious Diseases.
- 27 Jul 2012 Company added in the association field and additional lead trial centre identified as reported by ClinicalTrials.gov.
- 27 Jul 2012 Actual end date Sep 2010 added as reported by ClinicalTrials.gov.